p.53 抽出テキスト

August 1, 2017 Circulation. 2017;136:e60–e122. DOI: 10.1161/CIR.0000000000000499 e112

633.	 Miyake CY, Motonaga KS, Fischer-Colbrie ME, et al. Risk of cardiac disease and observations on lack of potential predictors by clinical history among children presenting for cardiac evaluation of mid-exertional syncope. Cardiol Young20151–7. 634.	 Ackerman MJ, Tester DJ, Porter CJ. Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome. Mayo Clin Proc. 1999;74:1088–94. 635.	 Schimpf R, Veltmann C, Wolpert C, et al. Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT. Herz. 2009;34:281–8. 636.	 Rossano J, Bloemers B, Sreeram N, et al. Efficacy of implantable loop recorders in establishing symptom-rhythm correlation in young patients with syncope and palpitations. Pediatrics. 2003;112:e228–e233. 637.	 Al Dhahri KN, Potts JE, Chiu CC, et al. Are implantable loop recorders useful in detecting arrhythmias in children with unexplained syncope? Pacing Clin Electrophysiol. 2009;32:1422–7. 638.	 Frangini PA, Cecchin F, Jordao L, et al. How revealing are insertable loop recorders in pediatrics? Pacing Clin Electrophysiol. 2008;31: 338–43. 639.	 Babikar A, Hynes B, Ward N, et al. A retrospective study of the clinical experience of the implantable loop recorder in a paediatric setting. Int J Clin Pract. 2008;62:1520–5. 640.	Ergul Y, Tanidir IC, Ozyilmaz I, et al. Evaluation rhythm problems in unexplained syncope etiology with implantable loop recorder. Pediatr Int. 2015;57:359–66. 641.	 Younoszai AK, Franklin WH, Chan DP, et al. Oral fluid therapy. A promising treatment for vasodepressor syncope. Arch Pediatr Adolesc Med. 1998;152:165–8. 642.	 Chu W, Wang C, Wu L, et al. Oral rehydration salts: an effective choice for the treatment of children with vasovagal syncope. Pediatr Cardiol. 2015;36:867–72. 643.	 Fouad FM, Sitthisook S, Vanerio G, et al. Sensitivity and specificity of the tilt table test in young patients with unexplained syncope. Pacing Clin Electrophysiol. 1993;16:394–400. 644.	 Grubb BP, Temesy-Armos P, Moore J, et al. The use of head-upright tilt table testing in the evaluation and management of syncope in children and adolescents. Pacing Clin Electrophysiol. 1992;15:742–8. 645.	 Numan M, Alnajjar R, Lankford J, et al. Cardiac asystole during head up tilt (HUTT) in children and adolescents: is this benign physiology? Pediatr Cardiol. 2015;36:140–5. 646.	 Qingyou Z, Junbao D, Jianjun C, et al. Association of clinical characteristics of unexplained syncope with the outcome of head-up tilt tests in children. Pediatr Cardiol. 2004;25:360–4. 647.	 Thilenius OG, Quinones JA, Husayni TS, et al. Tilt test for diagnosis of unexplained syncope in pediatric patients. Pediatrics. 1991;87:334–8. 648.	 Udani V, Bavdekar M, Karia S. Head up tilt test in the diagnosis of neurocardiogenic syncope in childhood and adolescence. Neurol India. 2004;52:185–7. 649.	 Yilmaz S, Gökben S, Levent E, et al. Syncope or seizure? The diagnostic value of synchronous tilt testing and video-EEG monitoring in children with transient loss of consciousness. Epilepsy Behav. 2012;24:93–6. 650.	 Alehan D, Celiker A, Ozme S. Head-up tilt test: a highly sensitive, specific test for children with unexplained syncope. Pediatr Cardiol. 1996;17:86–90. 651.	 Pongiglione G, Fish FA, Strasburger JF, et al. Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope. J Am Coll Cardiol. 1990;16:165–70. 652.	 Ross BA, Hughes S, Anderson E, et al. Abnormal responses to orthostatic testing in children and adolescents with recurrent unexplained syncope. Am Heart J. 1991;122:748–54. 653.	 Strieper MJ, Campbell RM. Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope. J Am Coll Cardiol. 1993;22:594–7. 654.	 Balaji S, Oslizlok PC, Allen MC, et al. Neurocardiogenic syncope in children with a normal heart. J Am Coll Cardiol. 1994;23:779–85. 655.	 Scott WA, Pongiglione G, Bromberg BI, et al. Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am J Cardiol. 1995;76:400–2. 656.	 McLeod KA, Wilson N, Hewitt J, et al. Cardiac pacing for severe childhood neurally mediated syncope with reflex anoxic seizures. Heart. 1999;82:721–5. 657.	 Kelly AM, Porter CJ, McGoon MD, et al. Breath-holding spells associated

with significant bradycardia: successful treatment with permanent pacemaker implantation. Pediatrics. 2001;108:698–702. 658.	 Zhang Q, Jin H, Wang L, et al. Randomized comparison of metoprolol ver-

sus conventional treatment in preventing recurrence of vasovagal syncope in children and adolescents. Med Sci Monit. 2008;14:CR199–CR203. 659.	 Müller G, Deal BJ, Strasburger JF, et al. Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am J Cardiol. 1993;71:592–5. 660.	 Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation. 2009;120:1679–86. 661.	 Kumar S, Tedrow UB, Triedman JK. Arrhythmias in adult congenital heart disease: diagnosis and management. Cardiol Clin. 2015;33:571–88.viii. 662.	 Murphy JG, Gersh BJ, Mair DD, et al. Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot. N Engl J Med. 1993;329:593–9. 663.	 Mylotte D, Pilote L, Ionescu-Ittu R, et al. Specialized adult congenital heart disease care: the impact of policy on mortality. Circulation. 2014;129:1804–12. 664.	 Khairy P, Landzberg MJ, Gatzoulis MA, et al. Value of programmed ventricular stimulation after tetralogy of Fallot repair: a multicenter study. Circulation. 2004;109:1994–2000. 665.	 Khairy P, Harris L, Landzberg MJ, et al. Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol. 2008;1:250–7. 666.	 Anpalahan M, Gibson S. The prevalence of neurally mediated syncope in older patients presenting with unexplained falls. Eur J Intern Med. 2012;23:e48–e52. 667.	 Richardson DA, Bexton RS, Shaw FE, et al. Prevalence of cardioinhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to the accident and emergency department with “unexplained” or “recurrent” falls. Pacing Clin Electrophysiol. 1997;20:820–3. 668.	 Paling D, Vilches-Moraga A, Akram Q, et al. Carotid sinus syndrome is common in very elderly patients undergoing tilt table testing and carotid sinus massage because of syncope or unexplained falls. Aging Clin Exp Res. 2011;23:304–8. 669.	 Rafanelli M, Ruffolo E, Chisciotti VM, et al. Clinical aspects and diagnostic relevance of neuroautonomic evaluation in patients with unexplained falls. Aging Clin Exp Res. 2014;26:33–7. 670.	 Shaw FE, Kenny RA. The overlap between syncope and falls in the elderly. Postgrad Med J. 1997;73:635–9. 671.	 Matthews IG, Tresham IA.E, Parry SW. Syncope in the older person. Cardiol Clin. 2015;33:411–21. 672.	 Newton J, Kenny R. Syncope and falls in older people: defining the size of the problem. Expert Rev Pharmacoecon Outcomes Res. 2001;1:187–97. 673.	 Duncan GW, Tan MP, Newton JL, et al. Vasovagal syncope in the older person: differences in presentation between older and younger patients. Age Ageing. 2010;39:465–70. 674.	 O’Dwyer C, Bennett K, Langan Y, et al. Amnesia for loss of consciousness is common in vasovagal syncope. Europace. 2011;13:1040–5. 675.	 Parry SW, Steen IN, Baptist M, et al. Amnesia for loss of consciousness in carotid sinus syndrome: implications for presentation with falls. J Am Coll Cardiol. 2005;45:1840–3. 676.	 Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139–46. 677.	 Grubb BP, Karabin B. Syncope: evaluation and management in the geriatric patient. Clin Geriatr Med. 2012;28:717–28. 678.	 Esposito C, Dal Canton A. Functional changes in the aging kidney. J Nephrol. 2010;23 Suppl 15:S41–5. 679.	 Racco F, Sconocchini C, Alesi C, et al. Long-term follow-up after syncope. A group of 183 patients observed for 5 years. Minerva Cardioangiol. 2000;48:69–78. 680.	 Kapoor WN, Hanusa BH. Is syncope a risk factor for poor outcomes? Comparison of patients with and without syncope. Am J Med. 1996;100:646–55. 681.	 Ruwald MH, Hansen ML, Lamberts M, et al. Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age. Am J Cardiol. 2013;112:1610–15. 682.	 Ungar A, Galizia G, Morrione A, et al. Two-year morbidity and mortality in elderly patients with syncope. Age Ageing. 2011;40:696–702. 683.	 Forman DE, Rich MW, Alexander KP, et al. Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol. 2011;57:1801–10. 684.	 O’Mahony D, Foote C. Prospective evaluation of unexplained syncope,

dizziness, and falls among community-dwelling elderly adults. J Gerontol A Biol Sci Med Sci. 1998;53:M435–M440.

Downloaded from http://ahajournals.org by on October 7, 2026